Development of water-soluble polyanionic carbosilane dendrimers as novel and highly potent topical anti-HIV-2 microbicides
- 31 July 2015
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 7 (35) , 14669-14683
Abstract
The development of topical microbicide formulations for vaginal delivery to prevent HIV-2 sexual transmission is urgently needed. Second- and third-generation polyanionic carbosilane dendrimers with a silicon atom core and 16 sulfonate (G2-S16), napthylsulfonate (G2-NS16) and sulphate (G3-Sh16) end-groups have shown potent and broad-spectrum anti-HIV-1 activity. However, their antiviral activity against HIV-2 and mode of action have not been probed. Cytotoxicity, anti-HIV-2, anti-sperm and antimicrobial activities of dendrimers were determined. Analysis of combined effects of triple combinations with tenofovir and raltegravir was performed by using CalcuSyn software. We also assessed the mode of antiviral action on the inhibition of HIV-2 infection through a panel of different in vitro antiviral assays: attachment, internalization in PBMCs, inactivation and cell-based fusion. Vaginal irritation and histological analysis in female BALB/c mice were evaluated. Our results suggest that G2-S16, G2-NS16 and G3-Sh16 exert anti-HIV-2 activity at an early stage of viral replication inactivating the virus, inhibiting cell-to-cell HIV-2 transmission, and blocking the binding of gp120 to CD4, and the HIV-2 entry. Triple combinations with tenofovir and raltegravir increased the anti-HIV-2 activity, consistent with synergistic interactions (CIwt: 0.33–0.66). No vaginal irritation was detected in BALB/c mice after two consecutive applications for 2 days with 3% G2-S16. Our results have clearly shown that G2-S16, G2-NS16 and G3-Sh16 have high potency against HIV-2 infection. The modes of action confirm their multifactorial and non-specific ability, suggesting that these dendrimers deserve further studies as potential candidate microbicides to prevent vaginal/rectal HIV-1/HIV-2 transmission in humans.Keywords
This publication has 73 references indexed in Scilit:
- Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIVAIDS, 2013
- Formulation, pharmacokinetics and pharmacodynamics of topical microbicidesBest Practice & Research Clinical Obstetrics & Gynaecology, 2012
- CCR5 Antagonist TD-0680 Uses a Novel Mechanism for Enhanced Potency against HIV-1 Entry, Cell-mediated Infection, and a Resistant VariantJournal of Biological Chemistry, 2012
- Measurement of Mucosal Biomarkers in a Phase 1 Trial of Intravaginal 3% StarPharma LTD 7013 Gel (VivaGel) to Assess Expanded SafetyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- Microbicides: Topical Prevention against HIVCold Spring Harbor Perspectives in Medicine, 2011
- HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo modelMucosal Immunology, 2010
- HIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with EndosomesCell, 2009
- Anionic Amphiphilic Dendrimers as Antibacterial AgentsJournal of the American Chemical Society, 2008
- Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virusProceedings of the National Academy of Sciences, 2008
- Cytotoxic effects of dimethyl sulphoxide (DMSO) on cochlear organotypic culturesHearing Research, 2008